Steven Zelenkofske - Net Worth and Insider Trading

Steven Zelenkofske Net Worth

The estimated net worth of Steven Zelenkofske is at least $905,721 dollars as of 2024-11-05. Steven Zelenkofske is the Chief Medical Officer of uniQure NV and owns about 159,458 shares of uniQure NV (QURE) stock worth over $905,721. Details can be seen in Steven Zelenkofske's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Zelenkofske has not made any transactions after 2018-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven Zelenkofske

To

Steven Zelenkofske Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Zelenkofske owns 4 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , uniQure NV (QURE) , and Regado Biosciences Inc (RGDO) among others .

Click here to see the complete history of Steven Zelenkofske’s form 4 insider trades.

Insider Ownership Summary of Steven Zelenkofske

Ticker Comapny Transaction Date Type of Owner
ACHN Achillion Pharmaceuticals Inc 2020-01-28 EVP & Chief Medical Officer
QURE uniQure NV 2018-06-06 Chief Medical Officer
RGDO Regado Biosciences Inc 2014-01-01 SVP & Chief Medical Officer
LIMIT LIMIT 2023-01-19 director

Steven Zelenkofske Latest Holdings Summary

Steven Zelenkofske currently owns a total of 1 stock. Steven Zelenkofske owns 159,458 shares of uniQure NV (QURE) as of June 6, 2018, with a value of $905,721.

Latest Holdings of Steven Zelenkofske

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QURE uniQure NV 2018-06-06 159,458 5.68 905,721

Holding Weightings of Steven Zelenkofske


Steven Zelenkofske Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Zelenkofske has made a total of 0 transactions in uniQure NV (QURE) over the past 5 years. The most-recent trade in uniQure NV is the sale of 23,929 shares on June 6, 2018, which brought Steven Zelenkofske around $888,723.

Insider Trading History of Steven Zelenkofske

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Zelenkofske Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steven Zelenkofske Ownership Network

Ownership Network List of Steven Zelenkofske

No Data

Ownership Network Relation of Steven Zelenkofske

Insider Network Chart

Steven Zelenkofske Owned Company Details

What does Achillion Pharmaceuticals Inc do?

Who are the key executives at Achillion Pharmaceuticals Inc?

Steven Zelenkofske is the EVP & Chief Medical Officer of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , General Counsel Martha E Manning , and director & Chief Executive Officer Joseph Truitt .

Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Achillion Pharmaceuticals Inc Insider Transactions

No Available Data

Steven Zelenkofske Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Zelenkofske. You might contact Steven Zelenkofske via mailing address: 120 Mountain View Boulevard, Basking Ridge Nj 07920.